• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot, Care Access says

cafead

Administrator
Staff member
  • cafead   Oct 12, 2023 at 11:42: AM
via The U.S. health regulator did not find any misconduct at clinical sites managed by Care Access for Pfizer (PFE.N) and French partner Valneva's (VLS.PA) trial of a Lyme disease vaccine candidate, the contract research firm said on Wednesday.

article source
 

<